Clinical variables of severe chronic spontaneous urticaria from total IgE standpoint: a retrospective study
R. Asero
Abstract
SUMMARY: Baseline total IgE show a high high prognostic value for omalizumab response with a threshold level of 18 IU/ml. Males seem more responsive to omalizumab. Most patients show a mixed clinical picture where signs of atopic status co-exist with signs of an autoimmune disease.
Topics & Concepts
MedicineOmalizumabImmunoglobulin EAtopyRetrospective cohort studyInternal medicineAllergyGastroenterologyImmunologyChronic urticariaImmunopathologyAutoimmunityAsthmaThyroidClinical significanceSubgroup analysisAllergic responseUrticaria and Related ConditionsDrug-Induced Adverse ReactionsSympathectomy and Hyperhidrosis Treatments